Parish LC |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group. |
1993 |
Int. J. Dermatol. |
pmid:8340194
|
MacGowan AR et al. |
Synergy testing of macrolide combinations using the chequerboard technique. |
1993 |
J. Antimicrob. Chemother. |
pmid:8144439
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Ximenes E et al. |
[Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria]. |
1993 |
Pathol. Biol. |
pmid:8233629
|
Peterson WL et al. |
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. |
1993 |
Am. J. Gastroenterol. |
pmid:8237933
|
Romand S et al. |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285620
|
Schmidt T et al. |
Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8288505
|
Walker LL et al. |
Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin. |
1993 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:8326182
|
Chien SM et al. |
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group. |
1993 |
Chest |
pmid:8449054
|
Watanabe Y et al. |
Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. |
1993 |
J. Antibiot. |
pmid:8501007
|
Roig J et al. |
Treatment of Legionnaires' disease. Current recommendations. |
1993 |
Drugs |
pmid:7691508
|
Dubois J et al. |
Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis. |
1993 |
Ear Nose Throat J |
pmid:8313865
|
Nasu M |
[Helicobacter pylori infections]. |
1993 |
Nippon Naika Gakkai Zasshi |
pmid:8315343
|
Braga PC and Piatti G |
Sub-lethal concentrations of clarithromycin interfere with the expression of Staphylococcus aureus adhesiveness to human cells. |
1993 |
J Chemother |
pmid:8371124
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Holdcroft C |
Two new macrolide antibiotics: clarithromycin and azithromycin. |
1993 |
Nurse Pract |
pmid:8380492
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|
Goldstein EJ and Citron DM |
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390810
|
Watanabe Y et al. |
Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives. |
1993 |
J. Antibiot. |
pmid:8360112
|